The finding of our study has indicated there was association between SNPs of XPG and survival in advanced NSCLC patients receiving platinum-based chemotherapy, and suggesting rs2296147 CT+TT and rs2094258 AG+GG contribute to the better survival of NSCLC. This evidence concerns the gene ERCC5 and non-small cell lung carcinoma.